Phage Therapy for Respiratory Tract Infections.
作者信息
Domingo-Calap Pilar, Pardo-Freire Marco, Bernabéu-Gimeno Mireia
机构信息
Institute for Integrative Systems Biology, University of Valencia-CSIC, Paterna, Spain.
出版信息
Open Respir Arch. 2025 May 13;6(Suppl 2):100440. doi: 10.1016/j.opresp.2025.100440. eCollection 2024 Oct.
Abstract
摘要
相似文献
1
Phage Therapy for Respiratory Tract Infections.
Open Respir Arch. 2025 May 13;6(Suppl 2):100440. doi: 10.1016/j.opresp.2025.100440. eCollection 2024 Oct.
2
Phage Therapy for Respiratory Infections: Opportunities and Challenges.
Lung. 2024 Jun;202(3):223-232. doi: 10.1007/s00408-024-00700-7. Epub 2024 May 21.
3
Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
Clin Pharmacol Ther. 2021 Jun;109(6):1443-1456. doi: 10.1002/cpt.2214. Epub 2021 Mar 25.
4
Phage therapy efficacy: a review of the last 10 years of preclinical studies.
Crit Rev Microbiol. 2020 Feb;46(1):78-99. doi: 10.1080/1040841X.2020.1729695. Epub 2020 Feb 24.
5
[Phage therapy for respiratory infections].
Rev Med Suisse. 2022 Nov 16;18(804):2150-2156. doi: 10.53738/REVMED.2022.18.804.2150.
6
The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages.
Antibiotics (Basel). 2025 Jan 14;14(1):87. doi: 10.3390/antibiotics14010087.
7
Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.
Expert Opin Drug Deliv. 2017 Aug;14(8):959-972. doi: 10.1080/17425247.2017.1252329. Epub 2016 Nov 10.
8
Phage therapy: breathing new tactics into lower respiratory tract infection treatments.
Eur Respir Rev. 2024 Jun 26;33(172). doi: 10.1183/16000617.0029-2024. Print 2024 Apr.
9
Expanding clinical phage microbiology: simulating phage inhalation for respiratory tract infections.
ERJ Open Res. 2021 Nov 8;7(4). doi: 10.1183/23120541.00367-2021. eCollection 2021 Oct.
10
Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.
Antimicrob Agents Chemother. 2014 Jul;58(7):4005-13. doi: 10.1128/AAC.02388-13. Epub 2014 May 5.
本文引用的文献
1
Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches.
J Clin Invest. 2025 Mar 3;135(5):e187996. doi: 10.1172/JCI187996.
2
Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients.
Med. 2024 Sep 13;5(9):1096-1111.e6. doi: 10.1016/j.medj.2024.05.017. Epub 2024 Jun 24.
3
Therapeutic Phage Monitoring: A Review.
Clin Infect Dis. 2023 Nov 2;77(Suppl 5):S384-S394. doi: 10.1093/cid/ciad497.
4
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
mBio. 2020 Aug 4;11(4):e01462-20. doi: 10.1128/mBio.01462-20.
5
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.
Sci Rep. 2016 May 26;6:26717. doi: 10.1038/srep26717.
6
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections.
Trends Microbiol. 2016 May;24(5):327-337. doi: 10.1016/j.tim.2016.01.008. Epub 2016 Mar 3.
7
Back to the future: bacteriophages as promising therapeutic tools.
HLA. 2016 Mar;87(3):133-40. doi: 10.1111/tan.12742. Epub 2016 Feb 19.
Zotero 插件